ATI PN PHARMACOLOGY PROCTORED ACTUAL EXAM
Questions and Verified Answers | 100% Correct | Grade A
2026 Updated | NCLEX-PN Pharmacology Competencies
SECTION 1: Pharmacokinetics and Pharmacodynamics (Q1-Q15)
Q1: A nurse is teaching a nursing student about the first-pass effect. Which statement by the student indicates
understanding?
A. "The first-pass effect occurs when a drug is metabolized in the liver before reaching systemic circulation."
[CORRECT]
B. "The first-pass effect occurs when a drug is excreted by the kidneys before reaching its target tissue."
C. "The first-pass effect increases the bioavailability of orally administered drugs."
D. "The first-pass effect occurs primarily with intravenously administered medications."
Correct Answer: A
Rationale: The first-pass effect refers to the metabolism of a drug by the liver before it enters systemic circulation, which
significantly reduces the bioavailability of orally administered drugs. Intravenous medications bypass the first-pass effect entirely
because they enter circulation directly. The first-pass effect decreases, not increases, bioavailability. Renal excretion is not related
to the first-pass effect, which is a hepatic phenomenon.
Q2: A nurse is caring for a client who is taking a highly protein-bound medication (98% bound to albumin). The
client's serum albumin level is 2.0 g/dL (low). Which effect should the nurse anticipate?
A. Decreased drug effect due to reduced free drug availability.
B. Increased drug effect and risk of toxicity due to higher free drug concentration. [CORRECT]
C. No change in drug effect because protein binding is not clinically significant.
D. Enhanced metabolism of the drug due to increased hepatic enzyme activity.
Correct Answer: B
Rationale: When a highly protein-bound drug is administered to a client with hypoalbuminemia (low albumin), fewer
protein-binding sites are available, resulting in more free (unbound) drug in the circulation. Free drug is pharmacologically active,
increasing the risk of toxicity and an exaggerated drug effect. This is particularly dangerous for drugs with a narrow therapeutic
index. Decreased free drug would occur with increased protein binding, not decreased. Protein binding is clinically significant for
highly bound drugs, and hypoalbuminemia does not directly affect hepatic enzyme activity.
Q3: A nurse is administering a medication to a client with a history of hepatic impairment. The nurse understands that
which pharmacokinetic phase is most likely to be affected?
A. Absorption of the drug from the GI tract.
B. Distribution of the drug to body tissues.
C. Metabolism of the drug by the liver. [CORRECT]
D. Excretion of the drug by the kidneys.
Correct Answer: C
Rationale: The liver is the primary organ responsible for drug metabolism, primarily through the cytochrome P450 enzyme system.
Hepatic impairment reduces the liver's ability to metabolize drugs, leading to drug accumulation and increased risk of toxicity.
,ATI PN Pharmacology Proctored Exam | 2026 Updated Questions and Verified Answers
Absorption occurs primarily in the GI tract and is not directly affected by hepatic function. Distribution depends on blood flow,
protein binding, and lipid solubility. Renal excretion is affected by kidney function, not liver function.
Q4: A nurse is reviewing the medication profile of a client who is taking phenytoin (Dilantin), a known enzyme
inducer. The provider prescribes an oral contraceptive. Which statement by the nurse best describes the potential drug
interaction?
A. "Phenytoin will increase the effectiveness of the oral contraceptive by enhancing its absorption."
B. "Phenytoin may reduce the effectiveness of the oral contraceptive by accelerating its metabolism."
[CORRECT]
C. "The oral contraceptive will increase phenytoin levels by inhibiting cytochrome P450 enzymes."
D. "There is no significant interaction between phenytoin and oral contraceptives."
Correct Answer: B
Rationale: Phenytoin is a potent cytochrome P450 enzyme inducer, which increases the rate of metabolism of other drugs
metabolized by the same enzyme system, including oral contraceptives. Accelerated metabolism reduces the half-life and serum
concentration of the oral contraceptive, potentially leading to contraceptive failure. Enzyme induction does not enhance
absorption; it increases metabolic breakdown. Phenytoin would not have its levels increased by oral contraceptives through this
mechanism, and the interaction is clinically significant enough that alternative contraception may need to be considered.
Q5: A nurse is caring for a client receiving gentamicin, an aminoglycoside antibiotic. The nurse understands that
which pharmacokinetic parameter is most important to monitor to prevent toxicity?
A. Absorption rate from the intramuscular injection site.
B. Volume of distribution in adipose tissue.
C. Serum peak and trough drug levels. [CORRECT]
D. First-pass metabolism by the liver.
Correct Answer: C
Rationale: Aminoglycosides such as gentamicin have a narrow therapeutic index and are associated with nephrotoxicity and
ototoxicity. Monitoring serum peak and trough levels is essential to ensure the drug concentration is within the therapeutic range —
high enough to be effective but low enough to avoid toxicity. The peak level indicates the highest concentration after
administration, while the trough indicates the lowest concentration before the next dose. Aminoglycosides are typically given IV or
IM, so absorption from the GI tract is not relevant. Aminoglycosides distribute primarily in extracellular fluid, not adipose tissue.
They are excreted renally, not metabolized by the liver.
Q6: A nursing instructor is teaching about drug-receptor interactions. Which explanation best describes the concept of
efficacy?
A. The ability of a drug to bind to a specific receptor.
B. The maximum effect a drug can produce regardless of dose. [CORRECT]
C. The dose of a drug required to produce 50% of the maximum effect.
D. The ratio of the toxic dose to the therapeutic dose.
Correct Answer: B
Rationale: Efficacy (also called intrinsic activity) refers to the maximum effect a drug can produce once it binds to its receptor,
regardless of the dose administered. A full agonist has high efficacy, while a partial agonist has lower efficacy and cannot
produce the same maximum effect even at full receptor occupancy. Affinity refers to the ability of a drug to bind to a receptor, not
the resulting effect. The dose required to produce 50% of the maximum effect is the ED50, which relates to potency. The ratio of
toxic dose to therapeutic dose describes the therapeutic index.
Q7: A nurse is caring for a client who has been taking a medication with a half-life of 12 hours. The nurse
understands that approximately how long it will take for the drug to reach steady-state concentration?
Page 2
,ATI PN Pharmacology Proctored Exam | 2026 Updated Questions and Verified Answers
A. 12 hours
B. 24 hours
C. 48 hours
D. 60 hours [CORRECT]
Correct Answer: D
Rationale: It takes approximately 4 to 5 half-lives for a drug to reach steady-state concentration, the point at which the rate of
drug administration equals the rate of elimination. With a half-life of 12 hours, steady state is achieved in 48 to 60 hours (4 × 12
= 48 hours; 5 × 12 = 60 hours). At steady state, drug accumulation plateaus and serum levels remain relatively constant between
doses. Twelve hours represents only one half-life, and 24 hours represents only two half-lives, which are insufficient for steady
state.
Q8: A nurse administers naloxone (Narcan) to a client experiencing opioid overdose. The nurse recognizes that
naloxone acts as which type of receptor antagonist?
A. Competitive antagonist that competes with the opioid for receptor binding. [CORRECT]
B. Noncompetitive antagonist that permanently alters the opioid receptor.
C. Partial agonist that partially activates the opioid receptor.
D. Inverse agonist that produces effects opposite to the opioid.
Correct Answer: A
Rationale: Naloxone is a competitive antagonist at mu-opioid receptors. It competes with opioid agonists for the same receptor
binding sites, displacing the opioid and reversing respiratory depression and sedation. Because it is a competitive antagonist, its
effects can be overcome by a sufficiently high dose of opioid agonist, which is why repeat dosing may be needed for long-acting
opioids. A noncompetitive antagonist binds irreversibly and cannot be displaced. A partial agonist produces some receptor
activation. An inverse agonist produces effects opposite to the agonist at the same receptor.
Q9: A nurse is caring for a pregnant client who was prescribed a medication for a chronic condition. The nurse is
concerned about the medication crossing the placental barrier. Which property of the drug most increases the
likelihood of placental transfer?
A. High molecular weight.
B. High degree of protein binding.
C. High lipid solubility. [CORRECT]
D. Ionized state at physiologic pH.
Correct Answer: C
Rationale: Lipid-soluble (lipophilic) drugs cross the placental barrier more easily because the placental membrane is composed of
lipid bilayers that allow passive diffusion of fat-soluble substances. Drugs with high molecular weight, high protein binding, or an
ionized state have greater difficulty crossing the placenta because they are too large, bound to carrier proteins, or not able to
passively diffuse through the lipid membrane. This pharmacokinetic principle is critical when evaluating medication safety during
pregnancy, as many drugs can reach the fetus and potentially cause harm.
Q10: A client with renal impairment is prescribed a medication that is primarily excreted by glomerular filtration.
Which adjustment should the nurse expect the provider to make?
A. Increase the frequency of dosing to maintain therapeutic levels.
B. Decrease the dose or increase the dosing interval to prevent drug accumulation. [CORRECT]
C. Switch to an inhaled route to bypass renal excretion entirely.
D. Add a protein-binding agent to enhance drug clearance.
Correct Answer: B
Rationale: When renal function is impaired, drugs that are primarily eliminated by glomerular filtration accumulate in the body
because the kidneys cannot efficiently clear them. The appropriate adjustment is to decrease the dose or extend the dosing interval,
Page 3
, ATI PN Pharmacology Proctored Exam | 2026 Updated Questions and Verified Answers
which prevents toxic drug accumulation while maintaining therapeutic effectiveness. Increasing the frequency of dosing would
worsen accumulation and toxicity. Changing to an inhaled route does not bypass renal excretion; excretion is independent of the
route of administration. There is no such thing as adding a protein-binding agent to enhance clearance.
Q11: A nurse is administering a newly prescribed drug with a very narrow therapeutic index. Which nursing action is
the highest priority?
A. Administer the medication with food to enhance absorption.
B. Monitor the client closely for signs of both therapeutic and toxic effects. [CORRECT]
C. Encourage the client to increase fluid intake to promote renal excretion.
D. Schedule the medication at bedtime to minimize side effects.
Correct Answer: B
Rationale: A narrow therapeutic index means there is a small margin between the therapeutic dose and the toxic dose, making the
drug potentially dangerous if serum levels rise even slightly above the therapeutic range. The highest priority is close monitoring for
both therapeutic and toxic effects, and therapeutic drug monitoring (serum levels) is often required. Administering with food,
increasing fluids, or scheduling at bedtime are not the primary safety concerns for narrow therapeutic index drugs. Examples
include digoxin, lithium, warfarin, phenytoin, and aminoglycosides.
Q12: A nurse is reviewing the dose-response curve for two medications, Drug A and Drug B. Drug A achieves its
maximum effect at 10 mg, while Drug B requires 50 mg to achieve the same maximum effect. The nurse correctly
identifies that Drug A is:
A. More efficacious than Drug B.
B. More potent than Drug B. [CORRECT]
C. Safer than Drug B.
D. More bioavailable than Drug B.
Correct Answer: B
Rationale: Potency refers to the amount of drug needed to produce a given effect. Drug A requires a lower dose (10 mg) to achieve
the same maximum effect as Drug B (50 mg), meaning Drug A is more potent. Potency is reflected by the position of the
dose-response curve along the x-axis (dose axis). Efficacy refers to the maximum achievable effect, and since both drugs reach the
same maximum effect, they have equal efficacy. Safety is determined by the therapeutic index, not potency. Bioavailability refers
to the fraction of the administered dose that reaches systemic circulation, which cannot be determined from the dose-response
curve alone.
Q13: A nurse is caring for a client receiving an intravenous medication and needs to draw a trough level. When should
the nurse obtain the blood sample?
A. 30 minutes after the infusion is complete.
B. Immediately before the next scheduled dose. [CORRECT]
C. At the midpoint between doses.
D. 1 hour before the infusion begins.
Correct Answer: B
Rationale: A trough level represents the lowest serum concentration of a drug and is drawn immediately before the next scheduled
dose. This timing ensures the sample reflects the drug concentration at its nadir, which is critical for determining whether the drug
has been adequately cleared between doses and for detecting potential drug accumulation. A peak level is drawn 30 minutes to 1
hour after the infusion is complete. Drawing at the midpoint between doses or 1 hour before infusion begins would not accurately
reflect the true trough level.
Q14: A nurse is caring for an older adult client who is taking multiple medications. The nurse understands that
age-related changes in pharmacokinetics most commonly result in which effect?
Page 4
Questions and Verified Answers | 100% Correct | Grade A
2026 Updated | NCLEX-PN Pharmacology Competencies
SECTION 1: Pharmacokinetics and Pharmacodynamics (Q1-Q15)
Q1: A nurse is teaching a nursing student about the first-pass effect. Which statement by the student indicates
understanding?
A. "The first-pass effect occurs when a drug is metabolized in the liver before reaching systemic circulation."
[CORRECT]
B. "The first-pass effect occurs when a drug is excreted by the kidneys before reaching its target tissue."
C. "The first-pass effect increases the bioavailability of orally administered drugs."
D. "The first-pass effect occurs primarily with intravenously administered medications."
Correct Answer: A
Rationale: The first-pass effect refers to the metabolism of a drug by the liver before it enters systemic circulation, which
significantly reduces the bioavailability of orally administered drugs. Intravenous medications bypass the first-pass effect entirely
because they enter circulation directly. The first-pass effect decreases, not increases, bioavailability. Renal excretion is not related
to the first-pass effect, which is a hepatic phenomenon.
Q2: A nurse is caring for a client who is taking a highly protein-bound medication (98% bound to albumin). The
client's serum albumin level is 2.0 g/dL (low). Which effect should the nurse anticipate?
A. Decreased drug effect due to reduced free drug availability.
B. Increased drug effect and risk of toxicity due to higher free drug concentration. [CORRECT]
C. No change in drug effect because protein binding is not clinically significant.
D. Enhanced metabolism of the drug due to increased hepatic enzyme activity.
Correct Answer: B
Rationale: When a highly protein-bound drug is administered to a client with hypoalbuminemia (low albumin), fewer
protein-binding sites are available, resulting in more free (unbound) drug in the circulation. Free drug is pharmacologically active,
increasing the risk of toxicity and an exaggerated drug effect. This is particularly dangerous for drugs with a narrow therapeutic
index. Decreased free drug would occur with increased protein binding, not decreased. Protein binding is clinically significant for
highly bound drugs, and hypoalbuminemia does not directly affect hepatic enzyme activity.
Q3: A nurse is administering a medication to a client with a history of hepatic impairment. The nurse understands that
which pharmacokinetic phase is most likely to be affected?
A. Absorption of the drug from the GI tract.
B. Distribution of the drug to body tissues.
C. Metabolism of the drug by the liver. [CORRECT]
D. Excretion of the drug by the kidneys.
Correct Answer: C
Rationale: The liver is the primary organ responsible for drug metabolism, primarily through the cytochrome P450 enzyme system.
Hepatic impairment reduces the liver's ability to metabolize drugs, leading to drug accumulation and increased risk of toxicity.
,ATI PN Pharmacology Proctored Exam | 2026 Updated Questions and Verified Answers
Absorption occurs primarily in the GI tract and is not directly affected by hepatic function. Distribution depends on blood flow,
protein binding, and lipid solubility. Renal excretion is affected by kidney function, not liver function.
Q4: A nurse is reviewing the medication profile of a client who is taking phenytoin (Dilantin), a known enzyme
inducer. The provider prescribes an oral contraceptive. Which statement by the nurse best describes the potential drug
interaction?
A. "Phenytoin will increase the effectiveness of the oral contraceptive by enhancing its absorption."
B. "Phenytoin may reduce the effectiveness of the oral contraceptive by accelerating its metabolism."
[CORRECT]
C. "The oral contraceptive will increase phenytoin levels by inhibiting cytochrome P450 enzymes."
D. "There is no significant interaction between phenytoin and oral contraceptives."
Correct Answer: B
Rationale: Phenytoin is a potent cytochrome P450 enzyme inducer, which increases the rate of metabolism of other drugs
metabolized by the same enzyme system, including oral contraceptives. Accelerated metabolism reduces the half-life and serum
concentration of the oral contraceptive, potentially leading to contraceptive failure. Enzyme induction does not enhance
absorption; it increases metabolic breakdown. Phenytoin would not have its levels increased by oral contraceptives through this
mechanism, and the interaction is clinically significant enough that alternative contraception may need to be considered.
Q5: A nurse is caring for a client receiving gentamicin, an aminoglycoside antibiotic. The nurse understands that
which pharmacokinetic parameter is most important to monitor to prevent toxicity?
A. Absorption rate from the intramuscular injection site.
B. Volume of distribution in adipose tissue.
C. Serum peak and trough drug levels. [CORRECT]
D. First-pass metabolism by the liver.
Correct Answer: C
Rationale: Aminoglycosides such as gentamicin have a narrow therapeutic index and are associated with nephrotoxicity and
ototoxicity. Monitoring serum peak and trough levels is essential to ensure the drug concentration is within the therapeutic range —
high enough to be effective but low enough to avoid toxicity. The peak level indicates the highest concentration after
administration, while the trough indicates the lowest concentration before the next dose. Aminoglycosides are typically given IV or
IM, so absorption from the GI tract is not relevant. Aminoglycosides distribute primarily in extracellular fluid, not adipose tissue.
They are excreted renally, not metabolized by the liver.
Q6: A nursing instructor is teaching about drug-receptor interactions. Which explanation best describes the concept of
efficacy?
A. The ability of a drug to bind to a specific receptor.
B. The maximum effect a drug can produce regardless of dose. [CORRECT]
C. The dose of a drug required to produce 50% of the maximum effect.
D. The ratio of the toxic dose to the therapeutic dose.
Correct Answer: B
Rationale: Efficacy (also called intrinsic activity) refers to the maximum effect a drug can produce once it binds to its receptor,
regardless of the dose administered. A full agonist has high efficacy, while a partial agonist has lower efficacy and cannot
produce the same maximum effect even at full receptor occupancy. Affinity refers to the ability of a drug to bind to a receptor, not
the resulting effect. The dose required to produce 50% of the maximum effect is the ED50, which relates to potency. The ratio of
toxic dose to therapeutic dose describes the therapeutic index.
Q7: A nurse is caring for a client who has been taking a medication with a half-life of 12 hours. The nurse
understands that approximately how long it will take for the drug to reach steady-state concentration?
Page 2
,ATI PN Pharmacology Proctored Exam | 2026 Updated Questions and Verified Answers
A. 12 hours
B. 24 hours
C. 48 hours
D. 60 hours [CORRECT]
Correct Answer: D
Rationale: It takes approximately 4 to 5 half-lives for a drug to reach steady-state concentration, the point at which the rate of
drug administration equals the rate of elimination. With a half-life of 12 hours, steady state is achieved in 48 to 60 hours (4 × 12
= 48 hours; 5 × 12 = 60 hours). At steady state, drug accumulation plateaus and serum levels remain relatively constant between
doses. Twelve hours represents only one half-life, and 24 hours represents only two half-lives, which are insufficient for steady
state.
Q8: A nurse administers naloxone (Narcan) to a client experiencing opioid overdose. The nurse recognizes that
naloxone acts as which type of receptor antagonist?
A. Competitive antagonist that competes with the opioid for receptor binding. [CORRECT]
B. Noncompetitive antagonist that permanently alters the opioid receptor.
C. Partial agonist that partially activates the opioid receptor.
D. Inverse agonist that produces effects opposite to the opioid.
Correct Answer: A
Rationale: Naloxone is a competitive antagonist at mu-opioid receptors. It competes with opioid agonists for the same receptor
binding sites, displacing the opioid and reversing respiratory depression and sedation. Because it is a competitive antagonist, its
effects can be overcome by a sufficiently high dose of opioid agonist, which is why repeat dosing may be needed for long-acting
opioids. A noncompetitive antagonist binds irreversibly and cannot be displaced. A partial agonist produces some receptor
activation. An inverse agonist produces effects opposite to the agonist at the same receptor.
Q9: A nurse is caring for a pregnant client who was prescribed a medication for a chronic condition. The nurse is
concerned about the medication crossing the placental barrier. Which property of the drug most increases the
likelihood of placental transfer?
A. High molecular weight.
B. High degree of protein binding.
C. High lipid solubility. [CORRECT]
D. Ionized state at physiologic pH.
Correct Answer: C
Rationale: Lipid-soluble (lipophilic) drugs cross the placental barrier more easily because the placental membrane is composed of
lipid bilayers that allow passive diffusion of fat-soluble substances. Drugs with high molecular weight, high protein binding, or an
ionized state have greater difficulty crossing the placenta because they are too large, bound to carrier proteins, or not able to
passively diffuse through the lipid membrane. This pharmacokinetic principle is critical when evaluating medication safety during
pregnancy, as many drugs can reach the fetus and potentially cause harm.
Q10: A client with renal impairment is prescribed a medication that is primarily excreted by glomerular filtration.
Which adjustment should the nurse expect the provider to make?
A. Increase the frequency of dosing to maintain therapeutic levels.
B. Decrease the dose or increase the dosing interval to prevent drug accumulation. [CORRECT]
C. Switch to an inhaled route to bypass renal excretion entirely.
D. Add a protein-binding agent to enhance drug clearance.
Correct Answer: B
Rationale: When renal function is impaired, drugs that are primarily eliminated by glomerular filtration accumulate in the body
because the kidneys cannot efficiently clear them. The appropriate adjustment is to decrease the dose or extend the dosing interval,
Page 3
, ATI PN Pharmacology Proctored Exam | 2026 Updated Questions and Verified Answers
which prevents toxic drug accumulation while maintaining therapeutic effectiveness. Increasing the frequency of dosing would
worsen accumulation and toxicity. Changing to an inhaled route does not bypass renal excretion; excretion is independent of the
route of administration. There is no such thing as adding a protein-binding agent to enhance clearance.
Q11: A nurse is administering a newly prescribed drug with a very narrow therapeutic index. Which nursing action is
the highest priority?
A. Administer the medication with food to enhance absorption.
B. Monitor the client closely for signs of both therapeutic and toxic effects. [CORRECT]
C. Encourage the client to increase fluid intake to promote renal excretion.
D. Schedule the medication at bedtime to minimize side effects.
Correct Answer: B
Rationale: A narrow therapeutic index means there is a small margin between the therapeutic dose and the toxic dose, making the
drug potentially dangerous if serum levels rise even slightly above the therapeutic range. The highest priority is close monitoring for
both therapeutic and toxic effects, and therapeutic drug monitoring (serum levels) is often required. Administering with food,
increasing fluids, or scheduling at bedtime are not the primary safety concerns for narrow therapeutic index drugs. Examples
include digoxin, lithium, warfarin, phenytoin, and aminoglycosides.
Q12: A nurse is reviewing the dose-response curve for two medications, Drug A and Drug B. Drug A achieves its
maximum effect at 10 mg, while Drug B requires 50 mg to achieve the same maximum effect. The nurse correctly
identifies that Drug A is:
A. More efficacious than Drug B.
B. More potent than Drug B. [CORRECT]
C. Safer than Drug B.
D. More bioavailable than Drug B.
Correct Answer: B
Rationale: Potency refers to the amount of drug needed to produce a given effect. Drug A requires a lower dose (10 mg) to achieve
the same maximum effect as Drug B (50 mg), meaning Drug A is more potent. Potency is reflected by the position of the
dose-response curve along the x-axis (dose axis). Efficacy refers to the maximum achievable effect, and since both drugs reach the
same maximum effect, they have equal efficacy. Safety is determined by the therapeutic index, not potency. Bioavailability refers
to the fraction of the administered dose that reaches systemic circulation, which cannot be determined from the dose-response
curve alone.
Q13: A nurse is caring for a client receiving an intravenous medication and needs to draw a trough level. When should
the nurse obtain the blood sample?
A. 30 minutes after the infusion is complete.
B. Immediately before the next scheduled dose. [CORRECT]
C. At the midpoint between doses.
D. 1 hour before the infusion begins.
Correct Answer: B
Rationale: A trough level represents the lowest serum concentration of a drug and is drawn immediately before the next scheduled
dose. This timing ensures the sample reflects the drug concentration at its nadir, which is critical for determining whether the drug
has been adequately cleared between doses and for detecting potential drug accumulation. A peak level is drawn 30 minutes to 1
hour after the infusion is complete. Drawing at the midpoint between doses or 1 hour before infusion begins would not accurately
reflect the true trough level.
Q14: A nurse is caring for an older adult client who is taking multiple medications. The nurse understands that
age-related changes in pharmacokinetics most commonly result in which effect?
Page 4
